The only comparison point we have for Transmedics was organOx which was acquired by a japanese conglomerate at more than 20x sales, with lower market shares and an inferior product to Transmedics (cannot flight in small jets due to its massive size).
It's not the best as acquisition are more expensive than the market's multiples but there is a huge disconnexion between those numbers still. Hence conservative.
Thank you for the writeup! If I may ask, how do you justify that P/S and P/E? How are these conservative?
The only comparison point we have for Transmedics was organOx which was acquired by a japanese conglomerate at more than 20x sales, with lower market shares and an inferior product to Transmedics (cannot flight in small jets due to its massive size).
It's not the best as acquisition are more expensive than the market's multiples but there is a huge disconnexion between those numbers still. Hence conservative.
https://substack.com/@wealthyreadings/note/c-148984599
Hands on the buy button! 😁
Thank you for taking us through an excellent quarter, very encouraged by management's plans and confidence.
Always my pleasure!